LIXTE BIOTECHNOLOGY HOLDINGS, INC. Financial Ratios
LIXT|FY2015 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2015 SEC 10-K data.
Key Data Points
- Altman Z-Score -11.44 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2015)
Return on Equity
-1040.5%
Profit Margin
-1383.1%
Net Income / Revenue
Asset Turnover
0.33
Revenue / Total Assets
Equity Multiplier
2.25
Total Assets / Equity
Composite: -1040.5% (reported: -1040.5%)
Profitability
Liquidity
Current Ratio
2.09
Quick Ratio
2.09
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.33
Inventory Turnover
-
Days Sales Outstanding
-
As of FY2015 · SEC 10-K · Updated Jun 24, 2026
Earnings Quality
Accrual Ratio
-195.6%
-408.8pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.